These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38744274)

  • 41. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
    Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F
    J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
    Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
    Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.
    Suárez-Calvet M; Araque Caballero MÁ; Kleinberger G; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Ewers M; Haass C;
    Sci Transl Med; 2016 Dec; 8(369):369ra178. PubMed ID: 27974666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue.
    Theoharides TC; Cholevas C; Polyzoidis K; Politis A
    Biofactors; 2021 Mar; 47(2):232-241. PubMed ID: 33847020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
    Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
    Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis.
    Liu D; Cao B; Zhao Y; Huang H; McIntyre RS; Rosenblat JD; Zhou H
    Neurosci Lett; 2018 Nov; 686():10-16. PubMed ID: 30171911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
    Williams GP; Yu ED; Shapiro K; Wang E; Freuchet A; Frazier A; Lindestam Arlehamn CS; Sette A; da Silva Antunes R
    Hum Immunol; 2024 May; 85(3):110770. PubMed ID: 38433036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.
    Rauchmann BS; Sadlon A; Perneczky R;
    J Alzheimers Dis; 2020; 73(4):1615-1626. PubMed ID: 31958095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
    J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study.
    Wright TJ; Pyles RB; Sheffield-Moore M; Deer RR; Randolph KM; McGovern KA; Danesi CP; Gilkison CR; Ward WW; Vargas JA; Armstrong PA; Lindsay SE; Zaidan MF; Seashore J; Wexler TL; Masel BE; Urban RJ
    Mol Cell Endocrinol; 2024 Jan; 579():112071. PubMed ID: 37816478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple early factors anticipate post-acute COVID-19 sequelae.
    Su Y; Yuan D; Chen DG; Ng RH; Wang K; Choi J; Li S; Hong S; Zhang R; Xie J; Kornilov SA; Scherler K; Pavlovitch-Bedzyk AJ; Dong S; Lausted C; Lee I; Fallen S; Dai CL; Baloni P; Smith B; Duvvuri VR; Anderson KG; Li J; Yang F; Duncombe CJ; McCulloch DJ; Rostomily C; Troisch P; Zhou J; Mackay S; DeGottardi Q; May DH; Taniguchi R; Gittelman RM; Klinger M; Snyder TM; Roper R; Wojciechowska G; Murray K; Edmark R; Evans S; Jones L; Zhou Y; Rowen L; Liu R; Chour W; Algren HA; Berrington WR; Wallick JA; Cochran RA; Micikas ME; ; Wrin T; Petropoulos CJ; Cole HR; Fischer TD; Wei W; Hoon DSB; Price ND; Subramanian N; Hill JA; Hadlock J; Magis AT; Ribas A; Lanier LL; Boyd SD; Bluestone JA; Chu H; Hood L; Gottardo R; Greenberg PD; Davis MM; Goldman JD; Heath JR
    Cell; 2022 Mar; 185(5):881-895.e20. PubMed ID: 35216672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
    Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
    Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19.
    Liu YH; Wang YR; Wang QH; Chen Y; Chen X; Li Y; Cen Y; Xu C; Hu T; Liu XD; Yang LL; Li SJ; Liu XF; Liu CM; Zhu J; Li W; Zhang LL; Liu J; Wang YJ
    Mol Neurodegener; 2021 Jul; 16(1):48. PubMed ID: 34281568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal Exploration of Cortical Brain Activity in Cognitive Fog: An EEG Study in Patients with and without Anosmia.
    Gangemi A; Suriano R; Fabio RA
    J Integr Neurosci; 2024 May; 23(5):105. PubMed ID: 38812399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.